Itamar Raz

Statistics

Publications

Citations

6.8K

H-Index

Active since

2015

Affiliations

Thrombolysis in Myocardial Infarction Study Group(Current)

Brigham and Women's Hospital

AstraZeneca (Sweden)

Hebrew University of Jerusalem

The University of Texas Southwestern Medical Center

Itamar Raz is an author at Thrombolysis in Myocardial Infarction Study Group specializing in medicine, cardiovascular pharmacotherapy, and diabetes mellitus.

Publications per year

2015–2024

Publications

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca et al. · New England Journal of Medicine · 2018 · 6.3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial

Ofri Mosenzon, Gil Leibowitz, Deepak L. Bhatt et al. · Diabetes Care · 2016 · 270 citations

Medicine, Internal Medicine, Pharmacology +12

Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial

Ofri Mosenzon, Cheryl Wei, Jaime A. Davidson et al. · Diabetes Care · 2015 · 66 citations

Medicine, Internal Medicine, Pharmacotherapy +14

Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk

Brian A. Bergmark, Benjamin M. Scirica, Philippe Gabríel Steg et al. · European Heart Journal · 2017 · 61 citations · Full text

Medicine, Cardiology, Diabetology +14

Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials

Nicholas Marston, James P. Pirruccello, Giorgio Melloni et al. · Nature Medicine · 2024 · 41 citations · Full text

Medicine, Cardiology, Hematology +16

1–5 of 7